Related Experiment Videos
Agar in the management of hyperbilirubinaemia in the premature baby
Insights
Oral agar supplementation did not significantly reduce serum bilirubin levels in low birthweight infants. This study suggests agar feeding is not a recommended treatment for hyperbilirubinemia in newborns.
Area of Science:
- Neonatal Medicine
- Pediatric Gastroenterology
Background:
- Hyperbilirubinemia is a common condition in newborn infants, particularly those with low birth weight.
- Effective management strategies for neonatal hyperbilirubinemia are crucial to prevent potential complications.
Purpose of the Study:
- To investigate the efficacy of oral agar supplementation in reducing serum bilirubin levels in low birthweight infants.
- To assess the safety and tolerability of oral agar administration in this population.
Main Methods:
- A randomized controlled trial involving eighty low birthweight infants (1500-2500 g).
- Infants were assigned to either an oral agar group or a control group.
- Agar was administered daily for 7 days at dosages of 600 mg/kg or 700 mg/kg, starting at 6-12 hours of age.
Main Results:
- No significant difference in serum bilirubin levels was observed between the agar-fed infants and the control group.
- No adverse complications were reported during the administration of oral agar.
- The study evaluated two different dosages and initiation times for agar supplementation.
Conclusions:
- Oral agar supplementation is not an effective treatment for managing hyperbilirubinemia in low birthweight newborn infants.
- Further research may be needed to explore alternative or adjunctive therapies for neonatal jaundice.
Abstract:
Eighty low birthweight infants (1500 to 2500 g) were randomly assigned to a group given oral agar and a control group. The study was first performed in 24 agar-fed babies and 24 control babies. The treated infants received a daily total amount of 600 mg/kg of agar beginning at 12 hours of age, for 7 days. In the later stage of the trial, 16 agar-fed babies and 16 control babies were investigated. The total daily amount of agar was raised to 700 mg/kg, beginning at 6 hours of age for 7 days. No complications were observed with the administration of agar. Serum bilirubin levels were not significantly lower in the agar-fed infants. We conclude that agar supplemented feeding is not indicated in the management of hyperbilirubinaemia in low birthweight newborn infants.